Skip to search formSkip to main contentSkip to account menu

Scenesse

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

afamelanotide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
TB vaccine upswing for GSK
NATuRe BIoTeChNology | VOL 37 | DeCeMbeR 2019 | 1385–1393 | www.nature.com/naturebiotechnology porphyria caused by a different… 
2013
2013
A bioassay for the detection of neutralizing antibodies against the α-melanocyte stimulating hormone analog afamelanotide in patients with erythropoietic protoporphyria.
2012
2012
Drug-induced pseudoleucoderma: a commentary.
© 2012 The Authors. doi: 10.2340/00015555-1235 Journal Compilation © 2012 Acta Dermato-Venereologica. ISSN 0001-5555 Sir, We read… 
2011
2011
A randomized phase III trial of afamelanotide (Scenesse®), an agonistic alpha-melanocyte-stimulating hormone (MSH) analogue in the treatment of protoporphyria-induced phototoxicity.
2004
2004
Forum
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)